title: Evaluation of oral hypo-osmolar glucose-based and rice-based oral rehydration solutions in the treatment of cholera in children.
abstract: In a randomized controlled clinical trial, the efficacy of a low-sodium low-glucose oral rehydration solution (ORS) and a low-sodium rice-based ORS was compared with standard WHO glucose ORS in the treatment of severe cholera in children aged 2-10y. In total, 120 children were evaluated for the study, of whom 58 patients were positive for Vibrio cholerae and were included in the study. Of these 58 cases, 19 received rice-based hypo-osmolar ORS, 20 received WHO-ORS and 19 received glucose-based hypo-osmolar ORS. The clinical characteristics (age, preadmission duration of diarrhoea, frequency of stool before admission, incidence of vomiting, body weight and volume of initial fluid requirement) were comparable in the three treatment groups. All patients received tetracycline in a dose of 50 mg/kg/d of body weight in 4 divided doses for 3 d.
  
  
  CONCLUSIONS
  Patients who received rice-based hypo-osmolar ORS had subsequently reduced (p < 0.05) stool output, ORS consumption and diarrhoea duration than the patients who received either WHO-ORS or glucose-based hypo-osmolar ORS.
authors.affiliation: National Institute of Cholera and Enteric Diseases, Beliaghata, Calcutta, India.
authors.forename: D
authors.initials: D
authors.lastname: Dutta
authors.forename: M K
authors.initials: MK
authors.lastname: Bhattacharya
authors.forename: A K
authors.initials: AK
authors.lastname: Deb
authors.forename: D
authors.initials: D
authors.lastname: Sarkar
authors.forename: A
authors.initials: A
authors.lastname: Chatterjee
authors.forename: A B
authors.initials: AB
authors.lastname: Biswas
authors.forename: K
authors.initials: K
authors.lastname: Chatterjee
authors.forename: G B
authors.initials: GB
authors.lastname: Nair
authors.forename: S K
authors.initials: SK
authors.lastname: Bhattacharya
mesh_terms: D002648:Child; D002675:Child, Preschool; D002771:Cholera / Q000628:therapy*; D005260:Female; D005440:Fluid Therapy / Q000379:methods*; D005947:Glucose / Q000627:therapeutic use; D006801:Humans; D008297:Male; D012275:Oryza / Q000627:therapeutic use*; D009994:Osmolar Concentration; D008517:Phytotherapy; D013752:Tetracycline / Q000008:administration & dosage / Q000627:therapeutic use; D014734:Vibrio cholerae / Q000302:isolation & purification; D014944:World Health Organization
chemical_list: D013752:Tetracycline; D005947:Glucose